Kevin Davies — SPARQNOW

At-a-Glance

Current Director, Professional Media Content Development at Sage (since 2025).
EVP/Executive Editor of The CRISPR Journal and GEN Biotechnology at Mary Ann Liebert, Inc. (since 2017).
Author of "EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing" (2020), supported by a Guggenheim Fellowship.
Authored "The $1,000 Genome" (2010), "Cracking the Genome" (2001), and "Breakthrough: The Race for the Breast Cancer Gene."
Co-author of "DNA: The Story of the Genetic Revolution" (2017) with Jim Watson and Andrew Berry.
Founding editor of Nature Genetics and Founding Editor-in-Chief of Bio-IT World.
Holds a PhD in molecular genetics from the University of London and an undergraduate degree in Biochemistry from Oxford University.

Biography

Kevin Davies serves as the Director of Professional Media Content Development at Sage and is the EVP/Executive Editor of The CRISPR Journal and GEN Biotechnology at Mary Ann Liebert, Inc. With over three decades in science publishing, he has held editorial leadership roles at prominent academic journals, including Nature Genetics, Nature, and Cell Press. He also spearheaded the launch of The CRISPR Journal in 2018 and GEN Biotechnology in 2022.